First Time Loading...

CareDx Inc
NASDAQ:CDNA

Watchlist Manager
CareDx Inc Logo
CareDx Inc
NASDAQ:CDNA
Watchlist
Price: 9.72 USD 4.85% Market Closed
Updated: May 4, 2024

CareDx Inc
Revenue

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

CareDx Inc
Revenue Peer Comparison

Comparables:
ABBV
GILD
AMGN
VRTX
REGN

Competitive Revenue Analysis
Latest Figures & CAGR of Competitors

Company Revenue CAGR 3Y CAGR 5Y CAGR 10Y
CareDx Inc
NASDAQ:CDNA
Revenue
$280.3m
CAGR 3-Years
13%
CAGR 5-Years
30%
CAGR 10-Years
29%
Abbvie Inc
NYSE:ABBV
Revenue
$54.3B
CAGR 3-Years
6%
CAGR 5-Years
11%
CAGR 10-Years
11%
Gilead Sciences Inc
NASDAQ:GILD
Revenue
$27.5B
CAGR 3-Years
2%
CAGR 5-Years
4%
CAGR 10-Years
7%
Amgen Inc
NASDAQ:AMGN
Revenue
$28.2B
CAGR 3-Years
4%
CAGR 5-Years
3%
CAGR 10-Years
4%
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
Revenue
$9.9B
CAGR 3-Years
17%
CAGR 5-Years
26%
CAGR 10-Years
23%
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
Revenue
$13.1B
CAGR 3-Years
16%
CAGR 5-Years
14%
CAGR 10-Years
20%

CareDx Inc
Revenue Breakdown

Breakdown by Geography
CareDx Inc

Total Revenue: 280.3m USD
100%
United States: 265.6m USD
94.8%
Europe: 10.2m USD
3.6%
Rest Of World: 4.5m USD
1.6%

Breakdown by Segments
CareDx Inc

Total Revenue: 280.3m USD
100%
Testing Services Revenue: 209.7m USD
74.8%
Patient And Digital Solutions: 37.1m USD
13.2%
Product Revenue: 33.5m USD
12%

See Also

What is CareDx Inc's Revenue?
Revenue
280.3m USD

Based on the financial report for Dec 31, 2023, CareDx Inc's Revenue amounts to 280.3m USD.

What is CareDx Inc's Revenue growth rate?
Revenue CAGR 10Y
29%

Over the last year, the Revenue growth was -13%. The average annual Revenue growth rates for CareDx Inc have been 13% over the past three years , 30% over the past five years , and 29% over the past ten years .